Sam Altman announced a $100 million OpenAI Foundation pledge to accelerate Alzheimer's research using artificial intelligence. In a TODAY interview with Maria Shriver, he highlighted AI's potential to improve early diagnosis, speed up drug discovery, and personalise treatment. Experts caution AI is powerful but depends on quality data, while Altman also addressed concerns about concentrated power.